Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Income After Taxes 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Takeda Pharmaceutical income after taxes for the quarter ending September 30, 2024 was $M, a 100% decline year-over-year.
  • Takeda Pharmaceutical income after taxes for the twelve months ending September 30, 2024 was $1.283B, a 9.29% decline year-over-year.
  • Takeda Pharmaceutical annual income after taxes for 2024 was $0.995B, a 57.59% decline from 2023.
  • Takeda Pharmaceutical annual income after taxes for 2023 was $2.346B, a 14.53% increase from 2022.
  • Takeda Pharmaceutical annual income after taxes for 2022 was $2.048B, a 42.07% decline from 2021.
  
Takeda Pharmaceutical Annual Income After Taxes
(Millions of US $)
2024 $995
2023 $2,346
2022 $2,048
2021 $3,536
2020 $407
2019 $981
2018 $1,680
2017 $1,074
2016 $693
2015 $-1,302
2014 $1,096
2013 $1,616
2012 $1,616
2011 $3,015
2010 $3,228
2009 $-4,623
Takeda Pharmaceutical Quarterly Income After Taxes
(Millions of US $)
2024-09-30
2024-06-30 $610
2024-03-31 $-46
2023-12-31 $719
2023-09-30 $-331
2023-06-30 $653
2023-03-31 $247
2022-12-31 $846
2022-09-30 $444
2022-06-30 $809
2022-03-31 $-703
2021-12-31 $509
2021-09-30 $419
2021-06-30 $1,824
2021-03-31 $1,843
2020-12-31 $887
2020-09-30 $38
2020-06-30 $767
2020-03-31 $389
2019-12-31 $-295
2019-09-30 $501
2019-06-30 $-188
2018-12-31 $337
2018-06-30 $718
2017-06-30 $1,305
2016-06-30 $933
2015-06-30 $209
2015-03-31 $3,673
2014-12-31 $1,064
2014-09-30 $4,076
2014-06-30 $336
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $300
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $1,104
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $42.160B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.364B 28.23
Chugai Pharmaceutical (CHGCY) Japan $72.468B 28.23
Merck (MKKGY) Germany $18.527B 16.59
Sandoz Group AG (SDZNY) Switzerland $17.930B 0.00
Astellas Pharma (ALPMY) Japan $17.409B 16.03
United Therapeutics (UTHR) United States $16.082B 15.82
Neurocrine Biosciences (NBIX) United States $13.958B 36.96
Summit Therapeutics (SMMT) United States $13.532B 0.00
Shionogi (SGIOY) Japan $11.859B 11.88
Madrigal Pharmaceuticals (MDGL) United States $6.844B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.477B 0.00
Corcept Therapeutics (CORT) United States $5.236B 39.66
Crinetics Pharmaceuticals (CRNX) United States $4.781B 0.00
PTC Therapeutics (PTCT) United States $3.539B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.817B 0.00
Dyne Therapeutics (DYN) United States $2.591B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.567B 11.63
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.404B 14.37
NewAmsterdam Pharma (NAMS) Netherlands $2.398B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.307B 0.00
Soleno Therapeutics (SLNO) United States $1.971B 0.00
Indivior (INDV) United States $1.723B 7.02
Xencor (XNCR) United States $1.665B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Ocular Therapeutix (OCUL) United States $1.374B 0.00
Harrow (HROW) United States $1.302B 0.00
Guardian Pharmacy Services (GRDN) United States $1.259B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.256B 0.00
Ardelyx (ARDX) United States $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.168B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.060B 0.00
ARS Pharmaceuticals (SPRY) United States $1.041B 0.00
Collegium Pharmaceutical (COLL) United States $0.923B 5.04
Bioventus (BVS) United States $0.863B 27.26
Cronos Group (CRON) Canada $0.788B 0.00
Relay Therapeutics (RLAY) United States $0.720B 0.00
Oruka Therapeutics (ORKA) United States $0.699B 0.00
USANA Health Sciences (USNA) United States $0.694B 12.86
Ironwood Pharmaceuticals (IRWD) United States $0.693B 0.00
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
Tourmaline Bio (TRML) United States $0.529B 0.00
Savara (SVRA) United States $0.527B 0.00
Xeris Biopharma Holdings (XERS) United States $0.516B 0.00
Verve Therapeutics (VERV) United States $0.509B 0.00
Altimmune (ALT) United States $0.506B 0.00
ProKidney (PROK) United States $0.505B 0.00
OmniAb (OABI) United States $0.494B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Siga Technologies (SIGA) United States $0.446B 5.20
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Akebia Therapeutics (AKBA) United States $0.415B 0.00
Korro Bio (KRRO) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.381B 0.00
Jupiter Neurosciences (JUNS) United States $0.347B 0.00
Avita Medical (RCEL) United States $0.335B 0.00
Aquestive Therapeutics (AQST) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.311B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.305B 123.71
4D Molecular Therapeutics (FDMT) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 16.00
Amylyx Pharmaceuticals (AMLX) United States $0.268B 0.00
Larimar Therapeutics (LRMR) United States $0.256B 0.00
Heron Therapeutics (HRTX) United States $0.243B 0.00
Profound Medical (PROF) Canada $0.237B 0.00
Inhibikase Therapeutics (IKT) United States $0.221B 0.00
Lexeo Therapeutics (LXEO) United States $0.221B 0.00
Silence Therapeutics (SLN) United Kingdom $0.215B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Lyell Immunopharma (LYEL) United States $0.188B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Acrivon Therapeutics (ACRV) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
VAXART, INC (VXRT) United States $0.163B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
Metagenomi (MGX) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.137B 0.00
Cassava Sciences (SAVA) United States $0.132B 0.00
Achieve Life Sciences (ACHV) Canada $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.121B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
ElectroCore (ECOR) United States $0.110B 0.00
Inotiv (NOTV) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
Context Therapeutics (CNTX) United States $0.089B 0.00
Century Therapeutics (IPSC) United States $0.088B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Journey Medical (DERM) United States $0.084B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.081B 21.25
PMV Pharmaceuticals (PMVP) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.069B 0.00
OptiNose (OPTN) United States $0.067B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.067B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
FibroGen (FGEN) United States $0.053B 0.00
Scienture Holdings (SCNX) United States $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
AleAnna (ANNA) United States $0.051B 0.00
Nutriband (NTRB) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.049B 0.00
Surrozen (SRZN) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.046B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
BioVie (BIVI) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Traws Pharma (TRAW) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
Jaguar Animal Health (JAGX) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.88